The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Targeting β-catenin/CBP interaction in breast cancer.
A. Ring
No relevant relationships to disclose
O. Evgrafov
No relevant relationships to disclose
J. Knwoles
Consultant or Advisory Role - Life Technologies (I)
Stock Ownership - Illumina
M. Kahn
Employment or Leadership Position - PRISM BioLab (U)
Consultant or Advisory Role - PRISM BioLab
Stock Ownership - PRISM BioLab